SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
TetraPhase Pharmaceuticals Announces Positive Phase 2 Data for Eravacycline (TP-434) in Patients With Complicated Intra-Abdominal Infections (cIAIs)